Interplay between inflammation and cancer

[1]  A. Roszak,et al.  The incidence of inflammation among patients suffering from cervix cancer with positive beta haemolytic streptococci cultures from genital tract. , 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[2]  R. Weinberg,et al.  The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy , 2018, Science Translational Medicine.

[3]  Muh-Hwa Yang,et al.  Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness , 2017, Molecular oncology.

[4]  Xia Li,et al.  Exposure to TNF‑α combined with TGF‑β induces carcinogenesis in vitro via NF-κB/Twist axis. , 2017, Oncology reports.

[5]  J. McCall,et al.  Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer , 2016, Clinical & translational immunology.

[6]  H. O’Hagan,et al.  Interplay Between Inflammation and Epigenetic Changes in Cancer. , 2016, Progress in molecular biology and translational science.

[7]  H. Zhang,et al.  High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery , 2015, Oncotarget.

[8]  W. Woodward,et al.  Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells , 2015, PloS one.

[9]  D. Vyas,et al.  Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. , 2015, World journal of gastroenterology.

[10]  Reka Albert,et al.  Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. , 2014, Cancer research.

[11]  H. Ji,et al.  TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling , 2014, Nature Communications.

[12]  Min Zhang,et al.  Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway. , 2014, Oncology reports.

[13]  A. Vecchione,et al.  Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling , 2014, Oncotarget.

[14]  Hirohito Yamaguchi,et al.  Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. , 2012, Cancer research.

[15]  P. Collin,et al.  Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4 , 2012, Journal of immunotherapy.

[16]  A. Mantovani,et al.  Cancer-related inflammation: common themes and therapeutic opportunities. , 2012, Seminars in cancer biology.

[17]  J. Santibañez,et al.  TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. , 2011, Clinical science.

[18]  Garret A. FitzGerald,et al.  Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[19]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[20]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[21]  K. O'Byrne,et al.  The role of inflammation in the pathogenesis of non-small cell lung cancer. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  David F Jarrard,et al.  Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.

[23]  E. Campbell,et al.  Metabolic Shifts in Immunity and Inflammation , 2010, The Journal of Immunology.

[24]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[25]  F. Balkwill.  Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[26]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[27]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[28]  Roger R. Gomis,et al.  TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.

[29]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[30]  F. Lovat,et al.  Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding , 2008, Clinical Cancer Research.

[31]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[32]  John T. Woosley,et al.  Circulating levels of inflammatory cytokines and risk of colorectal adenomas. , 2008, Cancer research.

[33]  J. Chirgwin,et al.  Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.

[34]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[35]  A. Pozzi,et al.  EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival , 2006, Oncogene.

[36]  A Schmidt,et al.  In memoriam of Rudolf virchow: a historical retrospective including aspects of inflammation, infection and neoplasia. , 2006, Contributions to microbiology.

[37]  M. Mueller.  Inflammation in epithelial skin tumours: old stories and new ideas. , 2006, European journal of cancer.

[38]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[39]  M. Huang,et al.  Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. , 2005, Cancer research.

[40]  T. Hla,et al.  Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor. , 2005, Prostaglandins & other lipid mediators.

[41]  Frederick W. Alt,et al.  DNA Repair, Genome Stability, and Aging , 2005, Cell.

[42]  M. Neurath,et al.  IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer , 2005, Cell cycle.

[43]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[44]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[45]  E. Bruyneel,et al.  [Cyclooxygenase 2 and carcinogenesis]. , 2004, Bulletin du cancer.

[46]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[47]  F. Balkwill,et al.  Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. , 2004, Oncogene.

[48]  Jung Mogg Kim,et al.  Helicobacter pylori infection activates NF-kappaB signaling pathway to induce iNOS and protect human gastric epithelial cells from apoptosis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[49]  Tomohiro Sawa,et al.  Chemical basis of inflammation-induced carcinogenesis. , 2003, Archives of biochemistry and biophysics.

[50]  A. Rashid,et al.  Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer , 2003, Gut.

[51]  L. Audoly,et al.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. , 2002, The Journal of clinical investigation.

[52]  J. Chirgwin,et al.  Transforming Growth Factor-Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways * , 2002 .

[53]  D. Korenaga,et al.  Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma. , 2002, Oncology reports.

[54]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[55]  J. Chirgwin,et al.  Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. , 2002, The Journal of biological chemistry.

[56]  R. Demicheli,et al.  Does surgery modify growth kinetics of breast cancer micrometastases? , 2001, British Journal of Cancer.

[57]  P K Lala,et al.  Role of nitric oxide in carcinogenesis and tumour progression. , 2001, The Lancet. Oncology.

[58]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[59]  N. Fausto,et al.  Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice , 2000, The Journal of experimental medicine.

[60]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[61]  J. Naismith,et al.  TNFα and the TNF receptor superfamily: Structure‐function relationship(s) , 2000, Microscopy research and technique.

[62]  G. Verdine,et al.  Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA , 2000, Nature.

[63]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[64]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. , 2000, International journal of cancer.

[65]  B. Halliwell.  Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. , 1999, Mutation research.

[66]  L. Marnett,et al.  Effects of nitric oxide and nitric oxide‐derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  S. Meltzer,et al.  Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. , 1999, Gastroenterology.

[68]  K. Haruma,et al.  Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[70]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.

[71]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  H. Ohshima,et al.  Formation of 8‐nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination , 1995, FEBS letters.

[73]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[74]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. , 1995, Cell.

[75]  M. Thun,et al.  Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop , 1994, Cancer.

[76]  H C Pitot,et al.  The molecular biology of carcinogenesis , 1993, Cancer.

[77]  A. Greenberg,et al.  Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. , 1993, The American journal of pathology.

[78]  R. Cooney,et al.  Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. , 1993, Carcinogenesis.

[79]  T. Wolff,et al.  Capability of human blood cells to form the DNA adduct, C8-(N2-aminofluorenyl)-deoxyguanosine-3'-5'-diphosphate from 2-aminofluorene. , 1990, Carcinogenesis.

[80]  N Gunduz,et al.  Presence of a growth-stimulating factor in serum following primary tumor removal in mice. , 1989, Cancer research.

[81]  J. Tavernier,et al.  EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.

[82]  S. Weitzman,et al.  Phagocytes as carcinogens: malignant transformation produced by human neutrophils. , 1985, Science.

[83]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.